H.R. 8425: Strengthening the Vaccines for Children Program Act of 2026
This bill, known as the Strengthening the Vaccines for Children Program Act of 2026, aims to enhance the accessibility and administration of vaccines for children, particularly through Medicaid and the Vaccines for Children program. It includes several key provisions:
1. Expansion of Vaccine Eligibility
The bill broadens the definition of a federally vaccine-eligible child to include:
- Children who receive a qualified pediatric vaccine and do not have insurance covering that vaccine.
- Children enrolled in state child health assistance programs.
2. Minimum Payment Requirements
The bill sets new payment guidelines for vaccine administration and counseling services under Medicaid:
- It establishes that providers must be paid at least 100% of the standard payment rate for these services, effective until December 31, 2028.
- It also alters regulations regarding managed care plans to ensure these payments are applied consistently across different healthcare providers.
3. Coverage of Services
The bill clarifies coverage for vaccine administration and counseling services under the Vaccines for Children program. It allows providers to charge administration fees, ensuring they do not exceed their operational costs for federally eligible children.
4. Increased Federal Assistance
The bill proposes an increase in the federal medical assistance percentage by 1%, starting in 2027. However, states must demonstrate effective communication strategies about vaccines to be eligible for this increase. This includes outreach regarding:
- The benefits of vaccines in preventing diseases.
- Immunization safety and community health protection.
- The risks associated with not vaccinating.
5. Access to Data for Tribal Centers
Tribal epidemiology centers will be allowed better access to health data necessary for monitoring child health and administering public health programs.
6. Reporting Requirements
The bill mandates the Centers for Disease Control and Prevention (CDC) to publish annual information on vaccination rates, disaggregated by demographic factors, to evaluate the effectiveness of the vaccination programs. Additionally, an analysis of the effects of these legislative changes on vaccination rates and provider participation must be submitted to Congress two years after enactment.
Relevant Companies
None found.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
9 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Apr. 21, 2026 | Introduced in House |
| Apr. 21, 2026 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.